Figure 2.
DNA damage response to genotoxin or telomere dysfunction in cells lacking either Wrn or p16Ink4a function. (A) Western blot analysis to determine the response of MEFs to doxorubicin treatment; (B) Western blot analysis to determine the response of MEFs to TRF2ΔBΔM overexpression. Wild type MEFs (WT) were used as controls; (C) SA-β-Gal staining of p16Ink4a−/−, Wrn−/− and p16Ink4a−/−Wrn−/− MEFs following TRF2ΔBΔM overexpression.